Hemostasis in the Very Young

Abstract

Hemostasis is a dynamic process that starts in utero. The coagulation system evolves with age, as evidenced by marked physiological differences in the concentration of the majority of hemostatic proteins in early life compared with adulthood. This concept, known as "developmental hemostasis," has important biological and clinical implications. Overall, impaired platelet function, along with physiologically reduced levels of vitamin K-dependent and contact coagulation factors, may cause poorer clot firmness even in healthy neonates. However, increased activity of von Willebrand factor and low levels of coagulation inhibitors that promote hemostasis counterbalance the delicate and immature hemostatic system. Since this hemostatic system has little reserve capacity, preterm neonates or sick infants are extremely vulnerable and predisposed to either hemorrhagic or thrombotic complications. This review will address the concept and manifestations of developmental hemostasis with respect to clinical disease phenotypes. It will discuss bleeding diagnosis in neonates, dealing especially with the devastating complications of intracerebral and pulmonary hemorrhage in preterm infants. Neonates, especially the sickest preterm ones, are also extremely susceptible to thrombotic complications; thus, thrombosis in neonates will be reviewed, with special focus on arterial ischemic perinatal stroke. Based on the concept of developmental hemostasis, the phenotypes of clinically relevant bleeding or thrombotic disorders among neonates may differ from those of older infants and children. Treatment options for these conditions will be suggested and reviewed.

Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia A

“…Importantly, early treatment initiation in PUPs may be able to decrease the incidence of intracranial hemorrhage, a potentially fatal complication encountered in infants with impaired hemostasis. 88 …”

Hemostatic Testing in Critically Ill Infants and Children

“…Indeed, assessment of hemostatic balance in patients with liver disease generally demonstrates a neutral or mildly pro-thrombotic hemostatic system (126,127). The concept of "hemostatic balance" has also been conceptually addressed as alternatively being a condition of a loss in "hemostatic reserve" by some hematologists, a concept that carries some merit (128). In the oncologic population, patients may be at risk of hyperviscosity, thrombosis, and cytopenias that may increase bleeding risk depending on the type of cancer and therapies.…”

Laboratory Markers in the Management of Pediatric Polytrauma: Current Role and Areas of Future Research

“…The hemostasis system of children significantly differs from that of adults, whereby the clinical interpretation of laboratory routine parameters might be challenging (59,60). Additionally, there is a clear lack of systematic studies investigating ATIC in children, which are needed to estimate its prognostic role as well as to define diagnostic and therapeutic strategies for ATIC treatment.…”

“…Nevertheless, the coagulation system is strongly dependent on patient age. Particularly newborns and toddlers present a lack of vitamin K dependent coagulation factors, less fibrinogen and reduced thrombocytes, displaying a higher risk for coagulopathy compared to older children and adults (59). The international normalized ratio (INR, >1.2-1.5) is frequently used to define coagulopathy in severely injured children.…”